Drought strikes May PBS listings

PBS listings have almost ground to a halt with only three additions to the scheme this month, compared to 17 in April and 12 in March.

Actor Pharmaceuticals had the biggest showing with Axhidrox listed on the PBS for primary axillary hyperhidrosis (PAHH) and Actobet listed for chronic stable plaque type psoriasis vulgaris. Both medicines were recommended at the PBAC’s November 2025 meeting.

Axhidrox contains glycopyrronium - the same active ingredient as Novartis’ COPD inhaler Seebri Breezhaler – but is formulated as a topical cream.